Position in HLN
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$158,311
-$172,699 QoQ
Shares Held
16,968
-48.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#34
of 83 holders
Holding Since
Dec 2022
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Versant Capital Management, Inc holds $2,428,042 across 29 Drug Manufacturers - Specialty & Generic names. HLN ranks #5 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
42,686 | $684,256 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
10,265 | $347,778 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
9,055 | $222,843 | |
| 4 | VTRS |
Viatris Inc
|
11,789 | $187,209 | |
| 5 | HLN |
Haleon plc
This page
|
16,968 | $158,311 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
737 | $124,213 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
182 | $98,613 | |
| 8 | ZTS |
Zoetis Inc.
|
1,244 | $89,393 |
All Filings in HLN
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $158,311 | 16,968 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $331,010 | 33,068 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $257,744 | 25,494 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $185,562 | 20,687 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $379,241 | 36,571 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $225,289 | 21,894 | Shares | Sole | 2025-04-03 | |
| 2024-12-31 | $33,514 | 3,513 | Shares | Sole | 2025-01-03 | |
| 2024-09-30 | $1,745 | 165 | Shares | Sole | 2024-10-07 | |
| 2023-12-31 | $246 | 30 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $249 | 30 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $251 | 30 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $244 | 30 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $240 | 30 | Shares | Sole | 2023-01-25 | |
| No filing history on record for this holder in this stock. | ||||||